旅行疫苗市場規模、佔有率和成長分析（按疫苗類型、疾病、旅行者類型和地區分類）－2025-2032年產業預測

全球旅行疫苗市場預計在 2023 年達到 41 億美元，從 2024 年的 43.1 億美元成長到 2032 年的 64.7 億美元，在預測期（2025-2032 年）內複合年成長率為 5.2%。

全球旅行疫苗市場正經歷顯著成長，這主要受多種因素影響，包括供需關係。休閒、商務和教育等國際旅行的增加，導致旅客接觸地方性感染疾病的機會增多，進一步強化了疫苗接種的需求。旅遊業，尤其是生態旅遊和前往偏遠地區的探險旅行，凸顯了疫苗接種的重要性。公眾和政府對感染疾病疫情的日益關注也推動了疫苗需求。許多國家要求入境時必須提供疫苗接種證明等監管規定，提高了疫苗接種的合規性，並促進了市場需求。疫苗研發的創新，特別是mRNA和重組技術，提高了疫苗的有效性和生產速度，增加了對這些產品的依賴。此外，醫療保健成本的上漲以及公共衛生機構所進行的旅客和疫苗接種教育推廣工作，也創造了新的市場機會。

全球旅行疫苗市場促進因素

全球旅行疫苗市場的主要驅動力是國際旅行和旅遊業的蓬勃發展，這顯著增加了人們感染疾病的風險。隨著越來越多的人因休閒、商務和留學等原因進行國際旅行，採取預防性健康措施（包括接種疫苗）來保護自身健康變得至關重要。民眾對疫苗可預防疾病的認知不斷提高，以及衛生部門的建議，進一步推動了旅遊疫苗的需求。此外，全球化、旅遊目的地多樣化以及各地不同的衛生法規等因素，也提高了人們對行前接種疫苗的意識，從而進一步促進了旅遊疫苗市場的成長。

限制全球旅行疫苗市場的因素

全球旅行疫苗市場的主要限制因素之一是各國法規結構和核准流程的差異。每個國家都制定了自己的疫苗接種指南，這可能導致疫苗的供應和接受度有差異。此外，基於錯誤訊息和文化信念的疫苗猶豫也可能阻礙市場成長。旅行限制和地緣政治因素也可能限制某些地區的疫苗供應。由於旅行者尋求疫苗安全性和有效性的保證，監管實踐的不一致可能會在全球範圍內阻礙人們對旅行疫苗的信任和接受度。

全球旅行疫苗市場趨勢

先進疫苗技術的整合正在改變全球旅行疫苗市場。 mRNA、重組和單劑量平台等創新技術能夠快速應對新出現的全球健康威脅，同時提高疫苗效力和分發效率。繼mRNA平台在新冠疫情期間取得成功後，主要企業正大力投資研發新型疫苗和聯合疫苗，以滿足現代旅客不斷變化的需求。這種前瞻性的方法不僅滿足了當前的醫療保健需求，也預見了未來疫苗監管政策的變化，從而確保了市場的持續成長和適應能力。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場概覽
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2024）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 技術評估
• 監管環境

旅行疫苗市場規模（依疫苗類型分類）及複合年成長率（2025-2032 年）

• 市場概覽
• 單劑疫苗
• 聯合疫苗

旅行疫苗市場規模（按疾病分類）及複合年成長率（2025-2032 年）

• 市場概覽
• 甲型肝炎
• B型肝炎
• 傷寒
• 黃熱病
• 狂犬病
• 腦膜炎奈瑟菌
• 日本腦炎
• 麻疹和腮腺炎
• 其他

旅行疫苗市場規模（依旅行者類型分類）及複合年成長率（2025-2032 年）

• 市場概覽
• 海外旅客
• 入境旅客
• 商務旅行
• 休閒旅遊

旅行疫苗市場規模及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2024 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2024 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2022-2024年營收年比比較

主要企業簡介

• GlaxoSmithKline plc
• Sanofi Pasteur
• Merck & Co., Inc.
• Novartis AG
• Pfizer Inc.
• Abbott Laboratories
• ALK-Abello A/S
• Bavarian Nordic A/S
• CSL Limited
• AstraZeneca plc
• Dynavax Technologies
• Emergent BioSolutions, Inc.
• Valneva SE
• Takeda Pharmaceutical Company
• Serum Institute of India Pvt. Ltd.
• Bharat Biotech International Ltd.
• Altimmune, Inc.
• LG Chem Ltd.（Life Sciences）
• Hualan Biological Engineering Inc.
• Mitsubishi Tanabe Pharma Corporation

結論與建議

Global Travel Vaccines Market size was valued at USD 4.1 billion in 2023 and is poised to grow from USD 4.31 billion in 2024 to USD 6.47 billion by 2032, growing at a CAGR of 5.2% during the forecast period (2025-2032).

The global travel vaccines market is experiencing significant growth propelled by various factors influencing both demand and supply dynamics. Increased global travel for leisure, business, and education has intensified the need for vaccinations, as travelers encounter region-specific infections. The thriving tourism sector, particularly eco-tourism and adventure travel to remote locations, underscores the critical nature of vaccination. Heightened public and governmental awareness of infectious disease outbreaks further drives vaccine demand. Regulatory mandates in numerous countries necessitating proof of vaccination for entry enhance compliance and market demand. Innovations in vaccine development, particularly through mRNA and recombinant technologies, improve efficacy and expedite creation, fostering greater reliance on these products. Additionally, rising healthcare costs and initiatives by public health agencies to educate travelers and promote immunization open new market opportunities.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Travel Vaccines market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Travel Vaccines Market Segments Analysis

Global Travel Vaccines Market is segmented by Vaccine Type, Disease, Traveler Type and region. Based on Vaccine Type, the market is segmented into Mono Vaccines and Combination Vaccines. Based on Disease, the market is segmented into Hepatitis A, Hepatitis B, Typhoid, Yellow Fever, Rabies, Meningococcal, Japanese Encephalitis, Measles & Mumps and Others. Based on Traveler Type, the market is segmented into Outbound Travelers, Inbound Travelers, Business Travel and Leisure Travel. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Travel Vaccines Market

A key market driver for the global travel vaccines market is the increasing international travel and tourism, which has significantly enhanced the risk of exposure to infectious diseases. As more individuals embark on international trips for leisure, business, or study, the need for preventative healthcare measures, including vaccinations, becomes paramount to safeguard health. Rising public awareness regarding vaccine-preventable diseases and recommendations from health authorities further propel the demand for travel vaccines. Additionally, factors such as globalization, diverse travel destinations, and varying health regulations strengthen the inclination for immunization prior to travel, fostering growth in the travel vaccines market.

Restraints in the Global Travel Vaccines Market

One key market restraint for the global travel vaccines market is the varying regulatory frameworks and approval processes across different countries. Each nation establishes its own guidelines for vaccine administration, which can lead to discrepancies in availability and acceptance. Additionally, the hesitance towards vaccinations due to misinformation or cultural beliefs can further inhibit market growth. Travel restrictions and geopolitical factors can also limit the accessibility of vaccines in certain regions. As travelers seek assurance regarding vaccine safety and efficacy, inconsistent regulatory practices may hinder the overall confidence and uptake of travel vaccines globally.

Market Trends of the Global Travel Vaccines Market

The Global Travel Vaccines market is witnessing a significant transformation driven by the integration of advanced vaccine technologies. Innovations such as mRNA, recombinant, and single-dose platforms are enabling faster responses to emerging global health threats while enhancing vaccine efficacy and improving distribution efficiencies. The success of mRNA platforms, highlighted during the COVID-19 pandemic, has prompted major companies to invest heavily in research for new and combination travel vaccines tailored to the evolving demands of contemporary travelers. This proactive approach not only addresses current healthcare needs but also anticipates future vaccine regulation changes, positioning the market for sustained growth and adaptability.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technology Assessment
• Regulatory Landscape

Global Travel Vaccines Market Size by Vaccine Type & CAGR (2025-2032)

• Market Overview
• Mono Vaccines
• Combination Vaccines

Global Travel Vaccines Market Size by Disease & CAGR (2025-2032)

• Market Overview
• Hepatitis A
• Hepatitis B
• Typhoid
• Yellow Fever
• Rabies
• Meningococcal
• Japanese Encephalitis
• Measles & Mumps
• Others

Global Travel Vaccines Market Size by Traveler Type & CAGR (2025-2032)

• Market Overview
• Outbound Travelers
• Inbound Travelers
• Business Travel
• Leisure Travel

Global Travel Vaccines Market Size & CAGR (2025-2032)

• North America (Vaccine Type, Disease, Traveler Type)
  • US
  • Canada
• Europe (Vaccine Type, Disease, Traveler Type)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Vaccine Type, Disease, Traveler Type)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Vaccine Type, Disease, Traveler Type)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Vaccine Type, Disease, Traveler Type)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• GlaxoSmithKline plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi Pasteur
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co., Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ALK-Abello A/S
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bavarian Nordic A/S
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CSL Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dynavax Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Emergent BioSolutions, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Valneva SE
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takeda Pharmaceutical Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Serum Institute of India Pvt. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bharat Biotech International Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Altimmune, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LG Chem Ltd. (Life Sciences)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hualan Biological Engineering Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mitsubishi Tanabe Pharma Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations